Penumbra (PEN) Other Operating Expenses (2018 - 2024)

Penumbra (PEN) reported Other Operating Expenses of $76.9 million for Q2 2024, up 322.43% quarter-over-quarter from $18.2 million in Q3 2023.

Penumbra (PEN) Other Operating Expenses (2018 - 2024) Analysis & Trends

Penumbra (PEN) has 3 years of Other Operating Expenses data on file, last reported at $76.9 million in Q2 2024.

Other Operating Expenses for Q2 2024 came in at $76.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $76.9 million (up 322.43% YoY), and the FY2024 annual result was $76.9 million, up 322.43% from the prior year.
Other Operating Expenses improved to $76.9 million in Q2 2024 per PEN's latest filing, from $18.2 million in the prior quarter.
Over five years, Other Operating Expenses peaked at $76.9 million in Q2 2024 and troughed at $18.2 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Penumbra	12.45 Bn	11.84 Bn	253.41 Mn

Download Data